Praha, Czechoslovakia

Gabriel Butora

This inventor holds 1 USPTO granted patent. Top assignee: Vyzkumny Ustav Pro Farmacii a Biochemii S.p.. Active years: 1995.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Gabriel Butora. Retrieved from https://idiyas.com/inventor/gabriel-butora

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 4.0

ph-index = 1


Company Filing History:


Years Active: 1995

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovations of Gabriel Butora

Introduction

Gabriel Butora is a notable inventor based in Praha, Czech Republic. He has made significant contributions to the field of pharmaceuticals and biochemistry. His work has led to the development of innovative compounds that have potential applications in various therapeutic areas.

Latest Patents

Gabriel Butora holds a patent for "N-arylalkylderivatives of 2-aminomethyl-2,3-dihydro-1,4-benzodioxine." This invention showcases his expertise in creating novel chemical compounds that may enhance drug efficacy and safety.

Career Highlights

Butora is affiliated with the Research Institute for Pharmacy and Biochemistry, where he has been instrumental in advancing research initiatives. His dedication to innovation in the pharmaceutical sector has earned him recognition among his peers.

Collaborations

Gabriel has collaborated with esteemed colleagues such as Miroslav Rajsner and Ivan Helfert. These partnerships have fostered a collaborative environment that encourages the exchange of ideas and expertise.

Conclusion

Gabriel Butora's contributions to the field of pharmaceuticals through his innovative patents and collaborative efforts highlight his commitment to advancing science and improving healthcare solutions.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…